Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties.
We sought to design ubiquitin-proteasome system inhibitors active against solid cancers by targeting ubiquitin receptor RPN13 within the proteasome's 19S regulatory particle. The prototypic bis-benzylidine piperidone-based inhibitor RA190 is a michael acceptor that adducts Cysteine 88 of RPN13....
Main Authors: | Ravi K Anchoori, Marietta Tan, Ssu-Hsueh Tseng, Shiwen Peng, Ruey-Shyang Soong, Aliyah Algethami, Palmer Foran, Samarjit Das, Chenguang Wang, Tian-Li Wang, Hong Liang, Chien-Fu Hung, Richard B S Roden |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0227727&type=printable |
Similar Items
-
Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor.
by: Ravi K Anchoori, et al.
Published: (2023-01-01) -
Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer.
by: Ravi K Anchoori, et al.
Published: (2024-01-01) -
Algorithms for RPN calculators /
by: 225388 Ball, John A.
Published: (1978) -
The influence of the Pringle maneuver in laparoscopic hepatectomy: continuous monitor of hemodynamic change can predict the perioperatively physiological reservation
by: Yi-Chan Chen, et al.
Published: (2023-06-01) -
Epidithiodiketopiperazines inhibit protein degradation by targeting Proteasome Deubiquitinase Rpn11
by: Li, Jing, et al.
Published: (2018)